Abiopharma

🔍 Grassi Joseph J III (Executive)

Company: loanDepot, Inc. (LDI)

Report Date: 2026-04-15

Detailed Transactions and Holdings:

• Acquired 46,099 shares of Class A Common Stock (Direct)
  Date: 2026-04-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 255,758.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 13,876 shares of Class A Common Stock at $1.55 per share (Direct)
  Date: 2026-04-15 | Code: F | equity_swap_involved: 0 | shares_owned_after: 241,882.00 | transaction_form_type: 4
• Acquired 46,099 shares of Class A Common Stock (Direct)
  Date: 2026-04-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 287,981.00 | transaction_form_type: 4 | Footnotes: F2, F3
• Sold 13,876 shares of Class A Common Stock at $1.55 per share (Direct)
  Date: 2026-04-15 | Code: F | equity_swap_involved: 0 | shares_owned_after: 274,105.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 46,099 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 46,099.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1
• Sold 46,099 shares of Performance Share Units (Derivative)
  Date: 2026-04-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 46,099.00 | transaction_form_type: 4 | Footnotes: F3, F2, F3, F3

Footnotes:

• F1: Each restricted stock unit ("RSU") represents a contingent right to receive, at settlement, one share of Class A Common Stock. The remaining RSUs are scheduled to vest on April 15, 2027.
• F2: The PSUs vested on April 15, 2026, and settled on April 16, 2026, due to an administrative processing delay. The tax-withholding price was based on April 15, 2026.
• F3: Each performance stock unit ("PSU") granted on April 15, 2024, represented a contingent right to receive one share of Class A Common Stock upon LDI achieving one fiscal quarter of positive adjusted net income. The remaining PSUs are scheduled to vest on April 15, 2027.